two-dimensional shear-wave elastography (SWE)
Otherperforma two-dimensional shear-wave elastography (SWE) for staging hepatic fibrosis in the background liver parenchyma in patients with liver tumors before hepatic resection
NCT Number: NCT02958592
To evaluate the diagnostic performance of two-dimensional shear-wave elastography (SWE) for staging hepatic fibrosis in the background liver parenchyma in patients with liver tumors before hepatic resection, using resected tissue pathology as a reference standard.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
performa two-dimensional shear-wave elastography (SWE) for staging hepatic fibrosis in the background liver parenchyma in patients with liver tumors before hepatic resection
Time frame: within the first 7 days after surgery
compare the stage of hepatic fibrosis between SWE test with specimens after surgery
Sun Yat-sen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03783871
Adenocarcinoma, Carcinoma
Guangzhou, Guangdong, China
View Trial DetailsNCT06060899
Adenocarcinoma, Carcinoma
Warsaw, Poland
View Trial DetailsNCT01812577
Adenocarcinoma, Carcinoma
Rome, Italy/RM, Italy
View Trial DetailsNCT02424955
Adenocarcinoma, Carcinoma
Stanford, California, United States
View Trial Details